| http://www.w3.org/ns/prov#value | - The latest results from the SPCG-4 trial indicate that surgery can not only improve survival, especially in men diagnosed at a younger age or with intermediate-risk disease, but also that surgery can reduce the burden of disease in terms of development of metastases and the need for palliative treatment, said co-author Jennifer Rider, assistant professor in the Department of Epidemiology at HSPH
|
